Replies to post #74854 on Decision Diagnostics Corp (DECN)

[tchalla]

hope decn doesn't get suspended, but looks like it could qualify for that action.

[Johnny_C]

If you go and read the annual report it went something like this;

1. Bozo berman had about $50k in the bank and was losing $250k a quarter in his failed glucose business

2. Bozo berman woke up one day in mid Febuary and saw Co Diagnostics price skyrocket

3. Bozo berman and Mathew Musho may have gotten drunk, started drinking pizza and then figured out they could do a pump and dump scam based on a 4.5 yr old research paper

4. Mathew Musho was the President of Bozo berman's former supplier, Conductive Technologies, whom DECN is suing for screwing DECn and its shareholders regarding the Johnson and Johnson situation; while Matthew Musho was President

5. They sketch up a little variation a $2.50 glucose device


6. Without any testing they put out a press release that they are jumping into the COVID testing market, the press release also babbles on about bozo bermans doggy diabetic strips


7. Supposedly, Bozo berman and Matthew Musho file a purported patent (s)


8. Bozo berman puts out a press release stating kits will be sold for personal use

9. Bozo berman puts out a release that he will sell 525 million devices in 12 months at about $8. or $4.3 billion bucks

That is one device for every man, woman and child in the US, Mexico and Canada. That is enough devices in 12 months to go around the equator approximately 2 times

10. Bozo berman states he can do this using his sole supplier, located at ground zero in South Korea. The Bio company...A small manufacturing company that is Bozo berman's sole supplier. Bozo berman is on the Board and that company is owned by hedge funds and investors.


PUMP PUMP PUMP and the Boat all the way to Bozo berman's bank account

[cvinvestor]

They mentioned in a previous PR that they had tested an impedance test kit successfully for H1N1 and something like "recently for the coronavirus which has a similar structure" or words to that effect.

Reading carefully through previous PRs will give you a lot of how this came about, but they have never shared whether they've tested 5 strips on 1 sample of blood or 100 test strips against 25 samples of blood.

Previously they shared that FDA told them they needed 30 dfferent blood samples if I recall correctly of venous blood which have been verified as coming from COVID-19 patients and others confirmed not being from COVID-19 patients in order to do their testing for the FDA EUA approval process.

So he is projecting complete confidence that the kits will pass the upcoming testing, but sure would be nice to know what that confidence is based on and share that with potential investors. There's no reason I can see to withhold that info as it would generate more interest than a Fortune 500 company being interested since the company's only interested if the test is really accurate and the FDA is warning people of non accurate tests.

You want this to skyrocket, reveal some hard core data on the test kit results. (if they are good, that is)